Skip to main content

Vital3D Technologies

ApplicationSunrise Tech Park, Vilnius, LithuaniaFounded 2021· One of 686 Application companies tracked by AMPulse

Vital3D Technologies develops a precision laser bioprinting platform (FemtoBrush) for medical devices, therapeutics and regenerative medicine, with lead programs in vascular stents and 3D cell culture systems.

CEO / Founder
Vidmantas Sakalys
Team Size
1-10
Stage
Active
Total Funding
$2.2M
Latest Round
Seed
Key Investors
Private Lithuanian businesses

Technology & Products

Key Products

Perfectly Fitted Stents (lead program - validated in animal trials), 3D Cell Culture Systems (validated in vitro), Implantable Grafts (prototype), Wound Patches (early development), Microfluidics (prototype), 3D bioprinted human organs (long-term goal)

Technological Advantage

Proprietary bioprinting technology combined with a phased go-to-market strategy starting in the veterinary sector to build proof-of-concept and drive revenue.

Differentiation

Value Proposition

For pets: accelerates wound healing and reduces treatment costs. For humans: addresses organ shortages and improves drug development through bioprinted tissues.

How They Differentiate

Focused initial entry into the veterinary wound care market with a validated product, reducing market risk before expanding to human applications.

Market & Competition

Target Customers

Veterinary clinics, pet owners; planned expansion to hospitals and healthcare providers.

Industry Verticals

Veterinary Medicine, Human Healthcare, Regenerative Medicine, Drug Discovery, Medical Devices

Competitors

Organovo Holdings Inc.; Poietis SA; Other emerging bioprinting companies

Growth & Milestones

Growth Metrics

Serviceable addressable market for pet wound care estimated at €76.5 million in the EU and US; planning to sell 100,000 units by 2027–2028.

Major Milestones

Development of VitalHeal bioprinted wound patch for pets, Scheduled clinical tests in Lithuania and the UK, Planned release of a non-degradable pet patch next year, Collaboration with Lithuania's National Cancer Institute

Notable Customers

null

https://vital3d.eu

Recent coverage of Vital3D Technologies

AM patents

AM-relevant patents linked to this company.

Patents
6
Granted
0
Families
5

Leading domains: equipment (6), process (6)

Filings by year: 2023: 6

  1. MULTI-MATERIAL OPTICAL 3D BIOPRINTER WITH INTEGRATED BIOREACTOR04469263 · EP
  2. MULTI-MATERIAL 3D MICRO-PRINTING IN LAMINAR FLOW2025141307 · WO
  3. MULTI-MATERIAL OPTICAL 3D BIOPRINTER WITH INTEGRATED BIOREACTOR2024218545 · WO
  4. METHOD AND SYSTEM FOR ELONGATING VOXEL IN MULTIPHOTON FABRICATION04429874 · EP
  5. METHOD AND SYSTEM FOR ELONGATING VOXEL IN MULTIPHOTON FABRICATION2024161177 · WO

Funding rounds

  • Grant€240K2024-07Source: Roots Analysis
  • Seed€2.0M2021-2022Source: Interhospi interview